Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T G Brott

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Critical Care Medicine|August 1, 1989
Use of high dose naloxone in acute stroke: possible side-effectsW G Barsan, C P Olinger, H P Adams, et al.
The American Journal of Emergency Medicine|January 1, 1989
Stroke patient evaluation in the emergency department before pharmacologic therapyB L Timerding, W G Barsan, J R Hedges, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 16, 2009
Prestroke physical activity and early functional status after strokeN Stroud, T M L Mazwi, L D Case, et al.
Neurology|March 23, 2005
Correlation of proband and sibling stroke latency: the SWISS StudyJ F Meschia, T G Brott, R D Brown, et al.
Annals of Emergency Medicine|November 1, 1988
Use of ancrod in acute or progressing ischemic cerebral infarctionC P Olinger, T G Brott, W G Barsan, et al.
Neurology|October 25, 2006
Family history of stroke and severity of neurologic deficit after strokeJ F Meschia, L D Case, B B Worrall, et al.
Stroke|May 1, 1990
High-dose intravenous naloxone for the treatment of acute ischemic strokeC P Olinger, H P Adams, T G Brott, et al.
Stroke|March 1, 1996
Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matterK R Wagner, G Xi, Y Hua, et al.
European Journal of Neurology|August 14, 2012
Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr9p21 are also associated with ischaemic strokeM G Heckman, A I Soto-Ortolaza, N N Diehl, et al.
Stroke|May 11, 1992
Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onsetE C Haley, D E Levy, T G Brott, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Critical Care Medicine|August 1, 1989
Use of high dose naloxone in acute stroke: possible side-effectsW G Barsan, C P Olinger, H P Adams, et al.
The American Journal of Emergency Medicine|January 1, 1989
Stroke patient evaluation in the emergency department before pharmacologic therapyB L Timerding, W G Barsan, J R Hedges, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 16, 2009
Prestroke physical activity and early functional status after strokeN Stroud, T M L Mazwi, L D Case, et al.
Neurology|March 23, 2005
Correlation of proband and sibling stroke latency: the SWISS StudyJ F Meschia, T G Brott, R D Brown, et al.
Annals of Emergency Medicine|November 1, 1988
Use of ancrod in acute or progressing ischemic cerebral infarctionC P Olinger, T G Brott, W G Barsan, et al.
Neurology|October 25, 2006
Family history of stroke and severity of neurologic deficit after strokeJ F Meschia, L D Case, B B Worrall, et al.
Stroke|May 1, 1990
High-dose intravenous naloxone for the treatment of acute ischemic strokeC P Olinger, H P Adams, T G Brott, et al.
Stroke|March 1, 1996
Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matterK R Wagner, G Xi, Y Hua, et al.
European Journal of Neurology|August 14, 2012
Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr9p21 are also associated with ischaemic strokeM G Heckman, A I Soto-Ortolaza, N N Diehl, et al.
Stroke|May 11, 1992
Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onsetE C Haley, D E Levy, T G Brott, et al.
Pageof 7